Long-read sequencing for undiagnosed genetic conditions
Part of Genetic & congenital clinical trials.
This trial uses advanced long-read sequencing technology to find genetic causes of diseases that standard tests may have missed. It may help people with undiagnosed conditions get a precise molecular diagnosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a suspected genetic cause for your condition.
- Your condition's molecular cause is either unknown or you have a clear need for genome-based diagnostics.
- You have been recommended for genome diagnostics, for example through the national genomic medicine initiative.
- You (or your legal guardian) must give informed consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses advanced DNA sequencing to figure out unclear or unusual blood (hematologic) conditions when standard tests are not enough. It may help your care team reach a more accurate diagnosis by better understanding what’s driving your illness.
This study helps decide treatment planning based on genetic testing for people whose disease cause is unclear but may be genetic. It’s meant to support a “genomic health” approach, where results guide next steps in care.
This trial uses advanced DNA testing to look for the genetic causes of certain rare diseases, including some intellectual development disorders and albinism. It may help people who haven't gotten a clear genetic answer from standard testing.
This study uses a new, high-resolution genome mapping technique to find genetic causes that standard tests might miss. It may help you if you have symptoms of a known genetic syndrome but standard testing came back negative or unclear.
This study offers genome sequencing (a complete look at your child's DNA) to help diagnose a suspected rare disease faster. It's for children who are newly referred to the genetics clinic at SickKids or CHEO and haven't had this type of testing before.
This research study tests a new way to screen newborns for hundreds of genetic diseases using a sample of their blood or saliva. It aims to find conditions early so your baby can get the right care sooner.
Hear when a new Genetic Predisposition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.